Financhill
Sell
37

MRNA Quote, Financials, Valuation and Earnings

Last price:
$27.42
Seasonality move :
23.68%
Day range:
$26.33 - $27.41
52-week range:
$23.15 - $170.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.32x
P/B ratio:
0.97x
Volume:
4.8M
Avg. volume:
9M
1-year change:
-74.84%
Market cap:
$10.6B
Revenue:
$3.2B
EPS (TTM):
-$9.28

Earnings Data

Next earnings date for MRNA
May 01
2025
Most recent earnings per share
-$2.91
Missed by $0.18
(Feb 14/2025)
Consensus Estimate
-$2.73
(Feb 14/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MRNA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $114.1M -- -- -$3.12 --
05/01/2025 Q1 $115.3M -- -- -$3.11 --
02/14/2025 Q4 $941.1M $956M -$2.91 -$2.73 -$0.18
11/07/2024 Q3 $1.2B $1.9B $0.03 -$1.94 $1.97
08/01/2024 Q2 $134.9M $221M -$3.33 -$3.36 $0.03
05/02/2024 Q1 $125.3M $167M -$3.07 -$3.55 $0.48
02/22/2024 Q4 $2.5B $2.8B $0.55 -$0.99 $1.54
11/02/2023 Q3 -- -- -$9.53 -$2.05 -$7.48
06/30/2023 Q2 -- -- -$3.62 -$4.12 $0.50
03/31/2023 Q1 -- -- $0.19 -$1.73 $1.92
12/31/2022 Q4 -- -- $3.61 $4.60 -$0.99
09/30/2022 Q3 -- -- $2.53 $3.11 -$0.58
06/30/2022 Q2 -- -- $5.24 $4.49 $0.75
03/31/2022 Q1 -- -- $8.58 -- --
12/31/2021 Q4 -- -- $11.29 -- --
09/30/2021 Q3 -- -- $7.70 -- --
06/30/2021 Q2 -- -- $6.46 -- --
03/31/2021 Q1 -- -- $2.84 -- --
12/31/2020 Q4 -- -- -$0.69 -- --
09/30/2020 Q3 -- -- -$0.59 -- --
06/30/2020 Q2 -- -- -$0.31 -- --
03/31/2020 Q1 -- -- -$0.35 -- --
12/31/2019 Q4 -- -- -$0.37 -- --
09/30/2019 Q3 -- -- -$0.37 -- --
06/30/2019 Q2 -- -- -$0.41 -- --
03/31/2019 Q1 -- -- -$0.40 -- --
12/31/2018 Q4 -- -- -$0.43 -- --
09/30/2018 Q3 -- -- -$0.27 -- --
06/30/2018 Q2 -- -- -$0.24 -- --
03/31/2018 Q1 -- -- -$0.19 -- --
12/31/2017 Q4 -- -- -$0.10 -- --

Moderna Earnings Questions

  • How Much did Moderna Generate in Revenue Last Quarter?

    Moderna reported $956M worth of top line sales in its most recent quarter.

  • Did Moderna Beat Earnings Last Quarter?

    Moderna announced earnings per share of -$2.91 which represents a miss of analyst forecast a -$2.73 per share.

  • Is Moderna Profitable?

    Moderna reported $217M that represents $0.56 per share over the last quarter.

  • What is the Analyst Consensus for Moderna EPS Next Year?

    Moderna's earnings are forecast to decrease from -$9.28 per share to -$9.03 per share next year representing a decrease of -11.15%.

  • When is Moderna's Earnings Date?

    Moderna's next earnings date is May 1, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Bill Ackman Buy Uber Stock?
Why Did Bill Ackman Buy Uber Stock?

In February, Pershing Square manager Bill Ackman revealed that his…

Should You Buy Alibaba Stock Despite the Risks?
Should You Buy Alibaba Stock Despite the Risks?

Markets rebounded slightly after U.S. President Donald Trump announced a…

Why Is Intel Struggling Against AMD?
Why Is Intel Struggling Against AMD?

Due to its disappointing reports, so-so management, and lack of…

Stock Ideas

Buy
59
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Buy
54
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 36x

Alerts

Sell
48
FI alert for Apr 25

Fiserv [FI] is up 1.06% over the past day.

Buy
66
FARO alert for Apr 25

Faro Technologies [FARO] is down 0.64% over the past day.

Buy
55
PI alert for Apr 25

Impinj [PI] is up 2.43% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock